Resonance Health Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
72.40
463.20
384.40
304.20
-
Depreciation, Depletion & Amortization
108.60
134.70
149.20
193.20
-
Other Funds
-
12.00
17.00
5.00
-
Funds from Operations
36.20
609.90
218.10
106.00
378.00
Changes in Working Capital
66.50
412.80
279.10
176.30
-
Net Operating Cash Flow
30.40
197.20
60.90
282.30
378.00
Capital Expenditures
194.80
170.60
340.90
477.90
546.60
Net Investing Cash Flow
194.80
170.60
340.90
504.60
546.60
Net Financing Cash Flow
1,228.80
631.30
-
-
-
Net Change in Cash
1,004.70
699.60
284.80
827.10
136.30
Free Cash Flow
34.80
185.80
2.80
305.70
363.10
Change in Capital Stock
1,228.80
631.30
-
-
-
Exchange Rate Effect
1.00
41.70
4.80
40.20
32.40
Other Uses
-
-
-
26.70
-

About Resonance Health

View Profile
Address
141 Burswood Road
Burswood Western Australia (WA) 6100
Australia
Employees -
Website http://www.resonancehealth.com
Updated 07/08/2019
Resonance Health Ltd. operates as a healthcare company, which involves in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment. It operates through the following segments: Services, Corporate, Research and Development. The company was founded by Santino Di-Giacomo in 1987 and is headquartered in Burswood, Australia.